Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood.
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
16
References
2
Citations
NaN
KQI